1. Adalimumab in the Treatment of Immune-Mediated Diseases. (January 2014) Authors: Lapadula, G.; Marchesoni, A.; Armuzzi, A.; Blandizzi, C.; Caporali, R.; Chimenti, S.; Cimaz, R.; Cimino, L.; Gionchetti, P.; Girolomoni, G.; Lionetti, P.; Marcellusi, A.; Mennini, F.S.; Salvarani, C. Journal: International journal of immunopathology and pharmacology Issue: Volume 27(2014) Supplement 1 Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS' ASSOCIATION (AMICI ONLUS). (September 2021) Authors: Costantino, A.; Noviello, D.; Conforti, F.S.; Aloi, M.; Armuzzi, A.; Bossa, F.; Ficari, F.; Leone, S.; Manguso, F.; Mocci, G.; Orlando, A.; Pironi, L.; Radice, S.; Rizzello, F.; Tongiorgi, A.; Costantino, C.; Vecchi, M.; Caprioli, F. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AF.52 LONG-TERM OUTCOME OF ACUTE SEVERE ULCERATIVE COLITIS RESPONSIVE TO INTRAVENOUS STEROID: A MULTICENTER IG-IBD STUDY. (September 2021) Authors: Festa, S.; Scribano, M.L.; Aratari, A.; Bezzio, C.; Principi, M.; Pugliese, D.; Ribaldone, D.G.; Furfaro, F.; Mocci, G.; Spagnuolo, R.; Vernia, P.; Costa, F.; Cosintino, R.; De Biasio, F.; Saibeni, S.; Armuzzi, A.; Papi, C. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab. (January 2014) Authors: Armuzzi, A.; Lionetti, P.; Blandizzi, C.; Caporali, R.; Chimenti, S.; Cimino, L.; Gionchetti, P.; Girolomoni, G.; Lapadula, G.; Marchesoni, A.; Marcellusi, A.; Mennini, F.S.; Salvarani, C.; Cimaz, R. Journal: International journal of immunopathology and pharmacology Issue: Volume 27(2014) Supplement 1 Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fecal HMGB1 reveals microscopic inflammation in adult and pediatric patients with inflammatory bowel disease who are in clinical and endoscopic remission. (10th October 2016) Authors: Palone, F.; Vitali, R.; Mennini, M.; Armuzzi, A.; D'Incà, R.; Aloi, M.; Oliva, S.; Dilillo, A.; Cucchiara, S.; Stronati, L. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 4 Page Start: e264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.02.1 IL-33 PROMOTES GUT MUCOSAL WOUND HEALING BY INDUCING MIRNA-320 TO STIMULATE EPITHELIAL RESTITUTION AND REPAIR. Issue 2 (15th March 2018) Authors: Lopetuso, L.R.; De Salvo, C.; Di Martino, L.; Rana, N.; Goodman, W.; Scaldaferri, F.; Armuzzi, A.; Gasbarrini, A.; Pizarro, T.T. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.02.5 EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR INFLIXIMAB (CT-P13) IN A LARGE COHORT OF IBD PATIENTS. (1st October 2020) Authors: Privitera, G.; Pugliese, D.; Tolusso, B.; Gremese, E.; Papa, A.; Papparella, L.G.; Gasbarrini, A.; Rapaccini, G.L.; Guidi, L.; Armuzzi, A. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.02.5 THE SOLUTE CARRIER LC22A4/OCTN1 AS A NOVEL IBD DETERMINANT AT THE MICROBE-HOST INTERFACE. (May 2022) Authors: Masi, L.; Petito, V.; Magrì, C.; Puca, P.; Fidaleo, M.; Palucci, I.; Del Chierico, F.; Ivagnes, V.; Mercuri, A.; Graziani, C.; Lopetuso, L.R.; Armuzzi, A.; Gasbarrini, A.; Pani, G.; Scaldaferri, F. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.04.2 ST2+/IL-33 RESPONSIVE CELLS PROMOTE TUMORIGENESIS IN COLITIS-ASSOCIATED COLORECTAL CANCER. (25th March 2019) Authors: Lopetuso, L.R.; De Salvo, C.; Di Martino, L.; Goodman, W.; Scaldaferri, F.; Armuzzi, A.; Gasbarrini, A.; Pizarro, T.T. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.04.3 REAL-LIFE VS TRIAL ACCESS TO BIOLOGIC THERAPY DIFFERENCES: A 2019-2020 EXPERIENCE IN AN ITALIAN TERTIARY IBD CENTER. (March 2023) Authors: Laterza, L.; Di Vincenzo, F.; Maresca, R.; Russo, M.C.; Mora, V.; Petito, V.; Turchini, L.; Amatucci, V.; Napolitano, D.; Schiavoni, E.; Settanni, C.; Parisio, L.; Pizzoferrato, M.; Lopetuso, L.; Armuzzi, A.; Gasbarrini, A.; Pugliese, D.; Scaldaferri, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗